LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged inherency · clear

Federal Circuit

Non-Prior Art Evidence May Be Used to Prove Inherency

HOSPIRA, INC. V. FRESENIUS KABI USA, LLC Before Lourie, Dyk, and Moore. Appeal from the U.S. District Court for the Northern District of Illinois. Summary: Evidence of the properties of claimed embodiments may be proper evidence of inherency, even when the…

January 9, 2020·Federal Circuit·2 min read
Federal Circuit

PERSONAL WEB TECHNOLOGIES, LLC v. APPLE, INC.

Federal Circuit Summary Before Moore, Taranto, and Chen . Appeal from the Patent Trial and Appeal Board. Summary : The mere fact that a certain thing may result from a given set of circumstances is not sufficient to demonstrate inherency. Instead, the…

March 8, 2019·Federal Circuit·1 min read
Federal Circuit

ACORDA THERAPEUTICS, INC. v. ROXANE LABORATORIES, INC.

Federal Circuit Summary Before Newman, Dyk, and Taranto . Appeal from the United States District Court for the District of Delaware. Summary : Pharmaceutical patents were obvious where the claims covered species of a genus taught by the prior art, the…

September 11, 2018·Federal Circuit·2 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data